Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Current Protocols
|
December 23, 2024
Using Vesicular Stomatitis Virus as a Platform for Directed Protease Evolution
Francesco Costacurta, Stefanie Rauch, Dorothee von Laer, et al.
Current Protocols
|
November 21, 2024
Vesicular Stomatitis Virus as a Platform for Protease Activity Measurements
Stefanie Rauch, Francesco Costacurta, Dorothee von Laer, et al.
Communications Biology
|
April 28, 2022
A VSV-based assay quantifies coronavirus Mpro/3CLpro/Nsp5 main protease activity and chemical inhibition
Emmanuel Heilmann, Francesco Costacurta, Stephan Geley, et al.
Npj Viruses
|
February 23, 2026
Study of key residues in MERS-CoV and SARS-CoV-2 main proteases for resistance against clinically applied inhibitors nirmatrelvir and ensitrelvir
Laura Krismer, Helge Schöppe, Stefanie Rauch, et al.
Npj Viruses
|
June 27, 2024
Study of key residues in MERS-CoV and SARS-CoV-2 main proteases for resistance against clinically applied inhibitors nirmatrelvir and ensitrelvir
Laura Krismer, Helge Schöppe, Stefanie Rauch, et al.
Science Translational Medicine
|
October 4, 2022
SARS-CoV-2 3CL<sup>pro</sup> mutations selected in a VSV-based system confer resistance to nirmatrelvir, ensitrelvir, and GC376
Emmanuel Heilmann, Francesco Costacurta, Seyed Arad Moghadasi, et al.
Science Advances
|
March 29, 2023
Transmissible SARS-CoV-2 variants with resistance to clinical protease inhibitors
Seyed Arad Moghadasi, Emmanuel Heilmann, Ahmed Magdy Khalil, et al.
Biorxiv : the Preprint Server for Biology
|
August 19, 2022
Transmissible SARS-CoV-2 variants with resistance to clinical protease inhibitors
Seyed Arad Moghadasi, Emmanuel Heilmann, Ahmed Magdy Khalil, et al.
Antiviral Research
|
July 25, 2024
Highly specific SARS-CoV-2 main protease (M<sup>pro</sup>) mutations against the clinical antiviral ensitrelvir selected in a safe, VSV-based system
Stefanie Rauch, Francesco Costacurta, Helge Schöppe, et al.
Biorxiv : the Preprint Server for Biology
|
October 9, 2023
A comprehensive study of SARS-CoV-2 main protease (M<sup>pro</sup>) inhibitor-resistant mutants selected in a VSV-based system
Francesco Costacurta, Andrea Dodaro, David Bante, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Current Protocols
|
December 23, 2024
Using Vesicular Stomatitis Virus as a Platform for Directed Protease Evolution
Francesco Costacurta, Stefanie Rauch, Dorothee von Laer, et al.
Current Protocols
|
November 21, 2024
Vesicular Stomatitis Virus as a Platform for Protease Activity Measurements
Stefanie Rauch, Francesco Costacurta, Dorothee von Laer, et al.
Communications Biology
|
April 28, 2022
A VSV-based assay quantifies coronavirus Mpro/3CLpro/Nsp5 main protease activity and chemical inhibition
Emmanuel Heilmann, Francesco Costacurta, Stephan Geley, et al.
Npj Viruses
|
February 23, 2026
Study of key residues in MERS-CoV and SARS-CoV-2 main proteases for resistance against clinically applied inhibitors nirmatrelvir and ensitrelvir
Laura Krismer, Helge Schöppe, Stefanie Rauch, et al.
Npj Viruses
|
June 27, 2024
Study of key residues in MERS-CoV and SARS-CoV-2 main proteases for resistance against clinically applied inhibitors nirmatrelvir and ensitrelvir
Laura Krismer, Helge Schöppe, Stefanie Rauch, et al.
Science Translational Medicine
|
October 4, 2022
SARS-CoV-2 3CL<sup>pro</sup> mutations selected in a VSV-based system confer resistance to nirmatrelvir, ensitrelvir, and GC376
Emmanuel Heilmann, Francesco Costacurta, Seyed Arad Moghadasi, et al.
Science Advances
|
March 29, 2023
Transmissible SARS-CoV-2 variants with resistance to clinical protease inhibitors
Seyed Arad Moghadasi, Emmanuel Heilmann, Ahmed Magdy Khalil, et al.
Biorxiv : the Preprint Server for Biology
|
August 19, 2022
Transmissible SARS-CoV-2 variants with resistance to clinical protease inhibitors
Seyed Arad Moghadasi, Emmanuel Heilmann, Ahmed Magdy Khalil, et al.
Antiviral Research
|
July 25, 2024
Highly specific SARS-CoV-2 main protease (M<sup>pro</sup>) mutations against the clinical antiviral ensitrelvir selected in a safe, VSV-based system
Stefanie Rauch, Francesco Costacurta, Helge Schöppe, et al.
Biorxiv : the Preprint Server for Biology
|
October 9, 2023
A comprehensive study of SARS-CoV-2 main protease (M<sup>pro</sup>) inhibitor-resistant mutants selected in a VSV-based system
Francesco Costacurta, Andrea Dodaro, David Bante, et al.
Page
of 2